articleTop 10% cited
Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial
Urology · 1999 · Vol. 54(6) · pp. 960–963
Daniel A. Shoskes✉(Harbor–UCLA Medical Center)Scott I. Zeitlin(University of California, Los Angeles)Asha Shahed(Harbor–UCLA Medical Center)Jacob Rajfer(UCLA Medical Center)
Hormonal and reproductive studiesBee Products Chemical AnalysisHealthcare and Venom ResearchMedicinePlaceboProstatitisInternal medicinePlacebo-controlled studyRandomized controlled trialDouble blindPhysical therapyProstateAlternative medicine
MeSH terms
AdultAgedChronic DiseaseDouble-Blind MethodHumansMaleMiddle AgedProspective StudiesProstatitisQuercetin
Citations
408
FWCI
8.73
field-weighted impact
References
30
Percentile
99%
vs. same field & year
Citations per year
Cited by
A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties
Food and Chemical Toxicology · 2007 · 872 citations
Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies
American Journal of Clinical Nutrition · 2005 · 1,326 citations
References
THE NATIONAL INSTITUTES OF HEALTH CHRONIC PROSTATITIS SYMPTOM INDEX: DEVELOPMENT AND VALIDATION OF A NEW OUTCOME MEASURE
The Journal of Urology · 1999 · 946 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.